[PLX] QoQ Quarter Result on 30-Sep-2021 [#Q3]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
15-Nov-2021
Financial Year
2021
Quarter
30-Sep-2021 [#Q3]
Profit Trend
QoQ- 62.65%
YoY- 5.36%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Quarter Result
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Revenue 8,753 16,085 8,549 12,054 6,427 11,320 19,495 -41.45%
PBT -5,334 -2,286 -6,667 -4,199 -11,241 -5,475 397 -
Tax -190 416 908 96 128 2,207 -212 -7.06%
NP -5,144 -2,702 -6,667 -4,199 -11,241 -5,475 397 -
Tax Rate - - - - - - 53.40% -
Total Cost 13,897 18,787 15,216 16,253 17,668 16,795 19,098 -19.14%
Ratio Analysis
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
NP Margin -58.77 -16.80 -77.99 -34.83 -174.90 -48.37 2.04 -
Per Share
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
EPS -0.11 -0.06 -0.15 -0.09 -0.25 -0.14 0.01 -
EPS Diluted -0.11 -0.06 -0.15 -0.09 -0.25 -0.14 0.01 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.